RAC confronts in utero gene therapy proposals.
Couzin
J
J
D000243:Adenosine Deaminase / Q000172:deficiency; D026683:Advisory Committees; D000818:Animals; D001805:Blood Transfusion, Intrauterine; D035082:Federal Government; D005315:Fetal Diseases / Q000628:therapy*; D033042:Fetal Research; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006801:Humans; D009316:National Institutes of Health (U.S.); D011640:Public Policy; D018570:Risk Assessment; D016511:Severe Combined Immunodeficiency / Q000628:therapy; D012941:Social Responsibility; D014481:United States; D017085:alpha-Thalassemia / Q000628:therapy
D000243:Adenosine Deaminase